Heterologous administration of tau vaccines
US11591377B2 · kind B2 · utility
1Cited by
6References
20Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Apr 23, 2020 |
| Grant date | Feb 28, 2023 |
| Priority date | — |
| Expiry date | Apr 23, 2040 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P25/28
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Methods for inducing an immune response against tau protein in a subject suffering from a neurodegenerative disease, disorder or condition, such as Alzheimer's Disease, are described. The methods include administering a liposomal priming composition containing tau peptides, preferably phosphorylated tau peptides, and a conjugate boosting composition containing tau peptides, preferably phosphorylated tau peptides, conjugated to an immunogenic carrier.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.